tiprankstipranks
Morphosys AG (DE:MOR)
XETRA:MOR

Morphosys (MOR) Technical Analysis

10 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Sell
0Bullish
5Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Morphosys AG’s (MOR) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Morphosys AG is a Sell.
Morphosys AG’s (MOR) 20-Day exponential moving average is 67.54, while Morphosys AG’s (MOR) share price is €67.8, making it a Buy.
Morphosys AG’s (MOR) 50-Day exponential moving average is 66.98, while Morphosys AG’s (MOR) share price is €67.8, making it a Buy.

Morphosys (MOR) Pivot Points

Jul 04, 2024, 06:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
67.08
67.27
67.43
67.62
67.78
67.97
68.13
Fibonacci
67.27
67.40
67.48
67.62
67.75
67.83
67.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Morphosys (MOR) Moving Averages

Jul 04, 2024, 06:25 AM
Period
Simple
Exponential
MA5
67.57Buy
67.58Buy
MA10
67.58Buy
67.54Buy
MA20
67.42Buy
67.54Buy
MA50
67.57Buy
66.98Buy
MA100
66.95Buy
62.85Buy
MA200
48.97Buy
50.64Buy
Morphosys AG’s (MOR) 10-Day exponential moving average is 67.54, while Morphosys AG’s (MOR) share price is €67.8, making it a Buy.
Morphosys AG’s (MOR) 100-Day exponential moving average is 62.85, while Morphosys AG’s (MOR) share price is €67.8, making it a Buy.
Morphosys AG’s (MOR) stock price is €67.8 and Morphosys AG’s (MOR) 50-day simple moving average is 67.57, creating a Buy signal.
Morphosys AG’s (MOR) stock price is €67.8 and Morphosys AG’s (MOR) 100-day simple moving average is 66.95, creating a Buy signal.
Morphosys AG’s (MOR) stock price is €67.8 and Morphosys AG’s (MOR) 200-day simple moving average is 48.97, creating a Buy signal.

Morphosys (MOR) Technical Indicators

Jul 04, 2024, 06:25 AM
Name
Value
Implied Action
RSI (14)
50.89
Neutral
STOCH (9,6)
55.40
Neutral
STOCHRSI (14)
90.35
Sell
MACD (12,26)
-0.01
Sell
ADX (14)
32.40
Neutral
Williams %R
-9.30
Sell
CCI (14)
24.94
Neutral
ATR (14)
0.70
-
Ultimate Oscillator
48.73
Neutral
ROC
0.00
-
Morphosys AG’s (MOR) Relative Strength Index (RSI) is 50.89, creating a Neutral signal.
Morphosys AG’s (MOR) Trend Strength Indicator (ADX) is 32.40, creating a Neutral signal.
Morphosys AG’s (MOR) Commodity Channel Index (CCI) is 24.94, creating a Neutral signal.

FAQ

Is MOR a Buy, Hold, or Sell?
Based on MOR’s technical indicators, MOR is a Buy.
    What is MOR’s RSI (14)?
    MOR’s RSI (14) is 50.89, which suggests MOR is a Neutral.
      What is MOR’s MACD?
      MOR’s MACD is -0.01, which suggests MOR is a Sell.
        What is MOR’s 5-day moving average?
        MOR’s 5-day moving average is 67.57, which suggests MOR is a Buy.
          What is MOR’s 20-day moving average?
          MOR 20-day moving average is 67.42, which suggests MOR is a Buy.
            What is MOR’s 50-day moving average?
            MOR’s 50-day moving average is 67.57, which suggests MOR is a Buy.
              What is MOR’s 200-day moving average?
              MOR’s 200-day moving average is 48.97, which suggests MOR is a Buy.
                What is MOR’s Williams % R (14)?
                MOR’s Williams % R (14) is -9.30, which suggests MOR is a Sell.
                  What is MOR’s CCI (14)?
                  MOR’s CCI (14) is 24.94, which suggests MOR is a Neutral.
                    What is the share price of Morphosys AG?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis